EUVIMEDEUVIMED entdecken
EditorialKommentar

Gender Equity in Clinical Trial Leadership—A Win-Win for Everyone

Grace Y Zhang, Ishani Ganguli, Tracy Y Wang

JAMA Internal Medicine · 2023

DOI: 10.1001/jamainternmed.2023.5091 ↗

Kurz gefasst

Editorial in der Zeitschrift JAMA Internal Medicine, 2023. Verfasst von Grace Y Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of California, San Francisco. Hauptthemen laut MEDLINE: Gender Equity, Leadership. Die Arbeit nennt 3 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gender EquityLeadershipHumansClinical Trials as Topic

Autor:innen und Institutionen

  • University of California, San Francisco.
  • Editorial Fellow, JAMA Internal Medicine.
  • Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Associate Editor, JAMA Internal Medicine.
  • Patient-Centered Outcomes Research Institute, Washington, DC.

Zitieren

APA

Zhang, G. Y., Ganguli, I., & Wang, T. Y. (2023). Gender Equity in Clinical Trial Leadership—A Win-Win for Everyone. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2023.5091

Vancouver

Zhang GY, Ganguli I, Wang TY. Gender Equity in Clinical Trial Leadership—A Win-Win for Everyone. JAMA Internal Medicine. 2023. doi:10.1001/jamainternmed.2023.5091

BibTeX
@article{Zhang2023,
  author = {Zhang, Grace Y and Ganguli, Ishani and Wang, Tracy Y},
  title = {Gender Equity in Clinical Trial Leadership—A Win-Win for Everyone},
  journal = {JAMA Internal Medicine},
  year = {2023},
  doi = {10.1001/jamainternmed.2023.5091}
}
Kostenlos starten →